Protecting Against Liver Damage Glutathione deficiency spells trouble for the liver, increasing the risk of cell damage
N.ColomL
scored positive top-line results in Transcend-T2D-1, a phase III trial evaluating the efficacy and safety of retatrutide, an investigational first-in-class GIP, GLP-1 and glucagon triple hormone receptor agonist, as an adjunct to diet and exercise in type 2 diabetes (T2D)
My recommendations here are the same as always: lots of fibre, adequate protein, healthy fats
CrossRef ABT-737 efficiently inhibits hepatocellular carcinoma cell activity via regulating PANoptosis Bi Deng, Xuefeng Jin, Dongmei Ye, Hefang Liu, Yunyun Qin, Xiaoyu Chen Discover Oncology .2026;[Epub] CrossRef Selinexor enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by regulating the BAX/Bcl-2/PUMA apoptotic pathway and the XPO1/p27 cell cycle pathway Shenghong Du, Ling Wang, Chen Chen, Yu Sun, Qian Liu, Jingfei Shi, Feng Zhang, Kai Wang, Chao Cui Frontiers in Oncology .2026;[Epub] CrossRef Juglans mandshurica-Eleutherococcus senticosus herb pair inhibits hepatocellular carcinoma growth by inducing immunogenic cell death via the HIF-1/STAT3 pathway Yu Jiang, Lili Jiang, He Zhang, Huiming Lv, Lina Xu, Linlin Zheng, Shengjin Yu Fitoterapia .2026
How this may impact your weight loss program Until now, GLP-1 weight loss programs in med spas have largely revolved around injectable semaglutide (Novo Nordisks Ozempic and Wegovy) or tirzepatide (Eli Lillys Zepbound)
